Show results for
Refine by
Spike Protein Suppliers Serving Namibia
30 companies found
based inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
The COVI-QUANT™ test will give you an answer. It represents the latest generation of testing technology that will provide a numerical value for your antibody level, not just yes or no. COVI-QUANT™ is an ELISA test available through ...
based inRoswell, GEORGIA (US) (USA)
OPTI Medical Systems, a subsidiary of IDEXX Laboratories, Inc., is an international and fast-growing diagnostics business with operations in Atlanta, Georgia, USA, serving the high-growth, near-patient testing market, targeting small- to ...
The OPTI SARS-CoV-2 Total Antibody Test is an enzyme-linked immunosorbent assay (ELISA) that detects total antibodies (IgG, IgM, and IgA) against the receptor binding domain (RBD) of the spike (S) protein of ...
based inMonthey, SWITZERLAND
We are a Swiss biologics CDMO (contract development and manufacturing organization) specializing in challenging protein expression services and based in Monthey, Switzerland. The heart of ExcellGene is applying smart science and technology to ...
In addition to stabilized trimeric spike proteins, we also offer the RBD domain produced in the same CHO cell system. The RBD protein is easier to produce and to purify and is therefore an ideal ...
based inShanghai City, CHINA
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ('Fosun Pharma'; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates ...
Messenger ribonucleic acid (mRNA) vaccines are a novel technology that stimulate the body’s own immune response. These vaccines contain information from messenger RNA, including the “blueprint” or code of a specific virus trait ...
based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
IVX-411 targets SARS-CoV-2, the coronavirus that causes COVID-19. Developed using cutting-edge structure-based design techniques at the Institute for Protein Design at the UW School of Medicine, IVX-411, our lead vaccine candidate ...
based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals ...
based inKAARINA, FINLAND
Labmaster Oy Ltd. is a company engaged in the design, development, and manufacturing of various products, ensuring they meet specified criteria through proper storage, usage, and transportation guidelines. They emphasize adherence to instructions ...
The Labmaster LUCIA™ SARS-CoV-2 IgG RBD test is meant for in vitro diagnostic qualitative detection of the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Receptor Binding Domain IgG antibodies from whole blood samples ...
based inPiscataway, NEW JERSEY (USA)
Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading ...
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 20SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease in 2019 ...
based inGeumcheon-gu, SOUTH KOREA
Since KogeneBiotech was founded in 2000, and our company has earned a reputation for innovation in Molecular Diagnostics. Our main business units are the production of Real-time PCR/conventional assay based on the active R&D works and testing ...
The SARS-CoV-2 variants can not only interrupt the formation of herd immunity through vaccination, but also the prevention and efficacy of the medical treatment. ...
based inStanmore, UNITED KINGDOM
Acellera’s mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning. In order to fulfill this vision, we work with our customers by becoming a key technology partner, boosting their ...
based inRedwood City, CALIFORNIA (USA)
Meissa Vaccines was founded with a mission to protect people everywhere from deadly respiratory viruses and a commitment to develop innovative technologies capable of delivering effective vaccines at a global scale. Meissa is developing live ...
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and ...
based inChatham, NEW JERSEY (USA)
Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. At Tonix, we are focused on ...
TNX-1850 is the planned new version of the TNX-1800 vaccine that encodes spike protein from SARS-CoV-2 BA.2 ...
based inPaoli, NEW JERSEY (USA)
Beta Lifescience is a professional biotech company committed to providing premium quality life science research reagents worldwide across research and diagnostic markets. Our strong portfolio of recombinant proteins, viral antigens, antibodies, ...
Anti-Spike RBD Protein of SARS-CoV-2 (2019-nCoV/Wuhan), Mouse Monoclonal ...
based inSALUGGIA, ITALY
We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years we have been dealing with diagnostics to help physicians and patients make better decisions in the ...
DiaSorin strives to improve health-care around the globe through the development of innovative diagnostic solutions that can lead to better patient outcomes and provide economic benefits to the healthcare system. Thanks to its team of dedicated ...
based inWurzburg, GERMANY
Virion\Serion, founded in 1978, is a company that has evolved over the last 40 years into a well-known and respected IVD manufacturer with one of the largest infectious disease portfolios for diagnosis of viral, bacterial, fungal and parasitic ...
Sometimes we are confronted with extreme situations that require extraordinary solutions. Our new product line supports in such situations and offers qualitative and quantitative immunoassays for the detection of human antibodies directed against ...
based inSan Jose, CALIFORNIA (USA)
Founded in 2005 and headquartered in San Jose, California, Advansta accelerates life science research by developing and supplying novel protein characterization tools that offer superior performance, simplicity, and convenience. Advansta’s mission ...
In December of 2019, the SARS-CoV-2 virus, which causes the disease COVID-19, was first detected in Wuhan, China. The SARS-CoV-2 virus is a single-stranded RNA coronavirus that causes respiratory infections. The rapid spread of COVID-19 has resulted ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Aloxistatin (E64d) is a cell-permeable and irreversible broad-spectrum cysteine protease inhibitor. Aloxistatin (E64d) exhibits entry-blocking effect for ...
based inWuhan, CHINA
Wuhan Healthcare Biotechnology Co., Ltd. (Healthcare) is specialized in the production of high quality in vitro diagnostic reagents and instrumentation products that empower clinicians to treat patients faster than before and intended for hospitals, ...
For qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, sodium citrate and lithium heparin) or fingerstick whole blood, venous whole blood specimens from patients suspected of COVID-19 ...
based inTainan City, TAIWAN
Leadgene Biomedical Inc. is founded in 2013 and headquarters in Tainan, Taiwan. In the past years, we have become an all-around solution provider for proteomics study with more than thirty staff members from a three-scientists workshop, ...
The neutralizing antibody blocks the interaction between RBD and ACE2. The uncut sheet must be further cut into individual strips. (Test line: spike ...
based inBelfast, UNITED KINGDOM
Biopanda Reagents develops and manufactures in vitro test kits for clinical laboratories, veterinary practice, environmental protection, and food safety, both locally and globally. Our company provides innovative, high quality and cost-effective ...
The Biopanda COVID-19 RBD IgG Rapid Test Kit is a highly sensitive, qualitative lateral flow immunochromatographic assay for the detection of specific anti-Receptor Binding Domain (RBD) IgG antibodies to SARS-CoV-2 in human whole blood, serum or ...